BTIG Reiterates Buy on Astrana Health, Maintains $50 Price Target

Benzinga Newsdesk www.benzinga.com Neutral 90.4%

Neg 0% Neu 90.4% Pos 0%

BTIG analyst David Larsen reiterates Astrana Health (NASDAQ:ASTH) with a Buy and maintains $50 price target.

Comments

No comments yet. Be the first!